New Mouse Models for Studies on Biomedical Complex Traits and Human Diseases and for Systems Genetics
Public support
Provider
Ministry of Education, Youth and Sports
Programme
COST CZ
Call for proposals
COST CZ 1 (SMSM2011LD1)
Main participants
—
Contest type
VS - Public tender
Contract ID
6884/2011-320
Alternative language
Project name in Czech
Nové myší modely pro studium biomedicínských komplexních znaků a lidských chorob a pro systémovou genetiku
Annotation in Czech
Cílem projektu je využití souboru chromozomálních substitučních kmenů jako modelových organismů pro studium dědičnosti exprese genů v různých tkáních v normálních a pathologických stavech, se zvláštním zaměřením na studium genů kontrolujících samčí neplodnost. Tento cíl pak realizovat ve spolupráci s evropskými pracovišti v rámci projektu SYSGENET a zajistit tak jeho integraci v rámci evropských genetických referenčních populací.
Scientific branches
R&D category
ZV - Basic research
CEP classification - main branch
EB - Genetics and molecular biology
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
FP - Other medical fields
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30101 - Human genetics<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>30501 - Forensic science<br>30502 - Other medical science<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Project enabled involvement of the laboratory in the program of European Cooperation in Science and Technology (COST) SYSGENET, focused on complex gene interactions using as a model mouse reference populations. The Prague laboratory contributed with a panel of chromosome substitution strains.
Solution timeline
Realization period - beginning
Mar 1, 2011
Realization period - end
Dec 31, 2013
Project status
U - Finished project
Latest support payment
Feb 22, 2013
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP14-MSM-LD-U/01:1
Data delivery date
Jun 30, 2014
Finance
Total approved costs
1,500 thou. CZK
Public financial support
1,500 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK